17-trans Prostaglandin E3 is primarily studied for its potential therapeutic applications in inflammation and cancer research. It has been shown to exhibit anti-inflammatory properties by modulating immune responses, making it a candidate for treating inflammatory diseases. Additionally, its role in inhibiting tumor growth and inducing apoptosis in cancer cells has garnered interest in oncology. Researchers are also exploring its effects on cellular signaling pathways, particularly those involving lipid metabolism and immune regulation, to develop targeted therapies. Its application in dermatology is also under investigation for skin repair and anti-aging treatments.